These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 11223270)
21. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome. Merritt TA; Hallman M; Spragg R; Heldt GP; Gilliard N Drugs; 1989 Oct; 38(4):591-611. PubMed ID: 2684594 [TBL] [Abstract][Full Text] [Related]
22. Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Wang JY; Yeh TF; Lin YC; Miyamura K; Holmskov U; Reid KB Thorax; 1996 Sep; 51(9):907-13. PubMed ID: 8984701 [TBL] [Abstract][Full Text] [Related]
23. Expanded use of surfactant therapy in newborns. Lacaze-Masmonteil T Clin Perinatol; 2007 Mar; 34(1):179-89, ix. PubMed ID: 17394937 [TBL] [Abstract][Full Text] [Related]
24. Functions of the surfactant proteins: a perspective. Hawgood S; Poulain FR Pediatr Pulmonol; 1995 Feb; 19(2):99-104. PubMed ID: 7659473 [No Abstract] [Full Text] [Related]
26. Animal studies of surfactant replacement therapy. Lachmann B Dev Pharmacol Ther; 1989; 13(2-4):164-72. PubMed ID: 2692999 [TBL] [Abstract][Full Text] [Related]
27. Surfactant-associated proteins: structure, function and clinical implications. Ketko AK; Donn SM Curr Pediatr Rev; 2014; 10(2):162-7. PubMed ID: 25088270 [TBL] [Abstract][Full Text] [Related]
28. Surfactant: current and potential therapeutic application in infants and adults. Lewis J; Veldhuizen RA J Aerosol Med; 1996; 9(1):143-54. PubMed ID: 10160204 [TBL] [Abstract][Full Text] [Related]
29. The 5 W's of surfactant for respiratory distress syndrome of the premature infant. Parmigiani S J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430 [TBL] [Abstract][Full Text] [Related]
30. The pulmonary surfactant system: biochemical and clinical aspects. Creuwels LA; van Golde LM; Haagsman HP Lung; 1997; 175(1):1-39. PubMed ID: 8959671 [TBL] [Abstract][Full Text] [Related]
34. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Pfister RH; Soll RF; Wiswell T Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826 [TBL] [Abstract][Full Text] [Related]
35. [Surfactant therapy in respiratory distress syndrome; a review]. de Winter JP; van Sonderen L; Egberts J; van Bel F Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2010-3. PubMed ID: 1407190 [No Abstract] [Full Text] [Related]
36. The surfactants. Kallapur S; Ikegami M Am J Perinatol; 2000; 17(7):335-43. PubMed ID: 12141520 [TBL] [Abstract][Full Text] [Related]
37. Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective. Morton NS Thorax; 1990 Nov; 45(11):825-30. PubMed ID: 2256008 [No Abstract] [Full Text] [Related]
38. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Elhalwagi BM; Zhang M; Ikegami M; Iwamoto HS; Morris RE; Miller ML; Dienger K; McCormack FX Am J Respir Cell Mol Biol; 1999 Sep; 21(3):380-7. PubMed ID: 10460755 [TBL] [Abstract][Full Text] [Related]
39. Pulmonary surfactant: functions, abnormalities and therapeutic options. Frerking I; Günther A; Seeger W; Pison U Intensive Care Med; 2001 Nov; 27(11):1699-717. PubMed ID: 11810113 [TBL] [Abstract][Full Text] [Related]